A small case-control study (151) demonstrated no significant effect of levothyroxine treatment in women with PCOS and SCH after multivariate analysis; none of the serum metabolic markers assessed, including LDL and HDL cholesterol, triglycerides, glucose, and insulin changed after treatment. The gene discussed is INS; the disease is spindle cell hemangioma.